Prosight Management LP Sells 381,667 Shares of KalVista Phar

Prosight Management LP cut its holdings in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Free Report) by 61.4% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 240,000 shares of the specialty pharmaceutical company’s stock after selling 381,667 shares during the quarter. KalVista Pharmaceuticals comprises […]

Related Keywords

Hong Kong , United States , Benjaminl Palleiko , Thomas Andrew Crockett , Kalvista Pharmaceuticals Company Profile , Nasdaq , Kalvista Pharmaceuticals , Kalvista Pharmaceuticals Inc , Kalvista Pharmaceuticals Trading , Securities Exchange Commission , News Ratings For Kalvista Pharmaceuticals Daily , Barclays Plc , Hong Kong Ltd , Quarter For Kalvista Pharmaceuticals , Cantor Fitzgerald , Prosight Management , Free Report , Vista Pharmaceuticals , Kong Ltd , Andrew Crockett , Exchange Commission , Get Free Report , Visit Holdingschannel , Kalvista Pharmaceuticals Daily , Nasdaq Kalv , Kalv , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,